Skip to main content
. 2019 Feb;40(1):5–22.

Table 3.

Response rates in myeloma (refs 104109).

Regimen Complete remission 1 year Overall Survival
Melphalan + prednisolone (MP) 2% 70%
Autologous stem cell transplantation 40% 80%
MP + thalidomide 16% 90%
MP + bortezomib 32% 92%
MP + lenalidomide 10% ~87%
Lenalidomide + dexamethasone 15% 94%
MP + bortezomib + daratumumab 43% ~90%